Colorectal Carcinoma
1 competing product in clinical development for Colorectal Carcinoma.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| IMC-1121B (ramucirumab) + Oxaliplatin + Folinic acid + 5-FU + 5-FU | Eli Lilly | Phase 2 | Completed | 52 |